美國的靜脈通路裝置市場:各產品類型，各用途，各終端用戶，各地區，機會，預測，2018年～2032年

美國血管通路設備市場規模預計將從 2024 年的 18.2275 億美元增長到 2032 年的 28.2064 億美元，在 2025-2032 年預測期內的複合年增長率為 5.59%。癌症、腎衰竭和糖尿病等慢性疾病的盛行率不斷上升，需要頻繁地進行血管介入治療。包括抗感染和壓力監測導管的開發在內的技術進步顯著提高了患者的安全性和手術效率。此外，對門診護理的日益增長的偏好和門診手術中心的擴張正在推動對先進血管通路解決方案的需求。

例如，碧迪公司（BD）於2024年10月推出了BD EZI-O腹腔內血管通路系統。此尖端工具可為重症監護患者在緊急情況下提供快速的血管通路。該技術旨在滿足緊急醫療需求，可透過骨髓快速有效地輸送液體和藥物。這項創新的目的是提高護理質量，特別是在休克、心臟驟停和創傷等棘手情況下的護理品質。

美國住院率與慢性病負擔上升

在美國，癌症、心血管疾病、糖尿病和慢性腎臟病等慢性疾病的流行是血管通路設備需求的主要驅動力。隨著人口老化和生活方式相關疾病的總體增加，需要長期靜脈治療、透析和化療的患者數量正在穩步增加。這些治療通常需要頻繁或持續地進入血液，因此血管通路裝置至關重要。此外，因外科手術和重症監護而住院和門診就診的人數激增，推動了對可靠、高效的血管通路解決方案的需求。隨著美國醫療保健系統不斷轉向提高病患安全性和減少導管相關併發症，具有增強生物相容性和感染預防功能的先進血管通路設備的使用也在增加。這證實了醫療保健對血管通路的廣泛需求及其在患者管理中的核心作用。例如，2024年2月，美國疾病管制與預防中心發布的數據顯示，大約每10個美國成年人中就有6人患有至少一種慢性病，每10人中就有4人患有兩種或兩種以上的慢性病，​​促使住院治療和長期照護的需求顯著增加。

本報告提供美國的靜脈通路裝置市場相關調查，提供市場概要，以及各產品類型，各用途，各終端用戶，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 美國的關稅的影響

第4章 摘要整理

第5章 美國的靜脈通路裝置市場預測，2018年～2032年

• 市場規模分析與預測
• 市場佔有率分析與預測
  • 各產品類型
    • 中心靜脈通路裝置
    • 末梢靜脈通路裝置
    • 配件
  • 各用途
    • 醫藥品管理局
    • 水分和營養的給藥
    • 輸血
    • 診斷
  • 各終端用戶
    • 醫院
    • 診所
    • 門診病人手術中心
    • 其他
  • 各地區
    • 東北部
    • 中西部
    • 西部
    • 南部
  • 各企業市場佔有率分析(前五名公司以及其他- 各金額，2024年)
• 2024年的市場地圖分析

第6章 價值鏈分析

第7章 需求供給分析

第8章 進出口的分析

第9章 波特的五力分析

第10章 大環境分析

第11章 價格分析

第12章 市場動態

• 市場促進因素
• 市場課題

第13章 市場趨勢與發展

第14章 法規結構和革新

第15章 競爭情形

• 前五名市場領導的競爭矩陣
• 前五名參與企業的SWOT分析
• 前10名市場主要企業的形勢
  • Becton Dickinson and Company
  • Teleflex Incorporated
  • Nipro Medical Corporation
  • ICU Medical, Inc.
  • AngioDynamics, Inc.
  • Medtronic plc
  • Braun Holding GMBH & Co. KG
  • Terumo Corporation
  • Cook Medical Inc.
  • Access Vascular Inc.

第16章 策略性建議

第17章 關於調查公司·免責聲明

United States vascular access devices market is projected to witness a CAGR of 5.59% during the forecast period 2025-2032, growing from USD 1,822.75 million in 2024 to USD 2,820.64 million in 2032. The rising prevalence of chronic conditions such as cancer, renal failure, and diabetes requires frequent vascular interventions. Technological advancements, including developing anti-infective and pressure-monitoring catheters, significantly improve patient safety and procedural efficiency. Moreover, the growing preference for outpatient care and the expansion of ambulatory surgical centers are fueling the demand for advanced vascular access solutions.

For instance, Becton, Dickinson and Company (BD) launched the BD EZI-O Intraosseous Vascular Access System in October 2024. This cutting-edge tool offers critical care patients' quick vascular access in emergencies. The technique, which was created to meet urgent medical needs, allows quick and effective delivery of fluids and medications through bone marrow. The goal of the innovation is to improve the quality of care, especially in difficult situations like shock, cardiac arrest, or trauma.

Rising Hospitalization Rates and Increasing Chronic Disease Burden in the U.S.

The growing prevalence of chronic diseases such as cancer, cardiovascular disorders, diabetes, and chronic kidney disease is significantly driving the demand for vascular access devices in the United States. With the aging population and an overall increase in lifestyle-related illnesses, the number of patients requiring long-term intravenous treatments, dialysis, or chemotherapy is rising steadily. These treatments typically involve frequent or continuous access to the bloodstream, making vascular access devices essential. Furthermore, the surge in hospital admissions and outpatient visits for surgical procedures and critical care support enhances the demand for reliable and efficient vascular access solutions. As the U.S. healthcare system continues to shift toward improving patient safety and reducing catheter-related complications, the usage of advanced vascular access devices with enhanced biocompatibility and infection-prevention features is also increasing. This driver underscores the broader healthcare need for vascular access and its central role in patient management. For example, in February 2024, the CDC published data showing that about 6 in 10 adults in the United States have at least one chronic disease, and 4 in 10 have two or more, significantly increasing hospital admissions and long-term care needs.

Technological Advancements in Vascular Access Devices Improve Patient Safety and Outcomes

Continuous innovation in vascular access technologies has been a significant growth factor in the United States market. Manufacturers focus on developing catheters and associated components that minimize the risk of bloodstream infections, thrombosis, and mechanical failures. Advanced coatings such as antimicrobial and antithrombogenic layers, integrated stabilization features, and closed catheter systems are widely used to enhance safety and reduce hospital-acquired infections. In addition, the integration of imaging-guided placement techniques such as ultrasound and real-time catheter tip positioning systems has improved the precision of device insertion and reduced complications. These technologies enhance patient safety and comfort and enable care providers to reduce the overall cost of complications and reductions. The growing demand for devices that support long-term access with minimal interventions is leading hospitals and clinics across the United States. to increasingly adopt next-generation vascular access devices, thereby contributing to overall market growth. Moreover, in July 2023, Access Vascular Inc. announced positive clinical results from its HydroPICC catheter, a peripheral vascular access device that significantly reduced complications like thrombosis and occlusion in a real-world clinical setting.

Peripheral Vascular Access Devices Hold a Significant Market Share

Peripheral vascular access devices represent a significant segment of the United States vascular access devices market, primarily due to their widespread use across multiple clinical applications. These devices are commonly used in inpatient and outpatient settings for short-term therapies such as hydration, medication delivery, and diagnostic testing. Their minimally invasive nature, ease of insertion, and lower complication rates make them a preferred option for emergency care, pediatric treatments, and routine hospital procedures. Midline catheters and peripheral intravenous (PIV) lines have seen increased adoption due to their suitability for intermediate-duration therapies, reducing the need for more invasive central lines. With an increasing number of ambulatory surgeries and a rise in emergency department visits across the United States, peripheral vascular access solutions are in high demand. Their versatility, cost-effectiveness, and growing technological improvements-such as self-sealing valves and securement systems-further accelerate the segment's growth trajectory. In May 2023, Teleflex Incorporated launched the Arrow VPS Rhythm DLX Device, a vascular positioning system with electrocardiogram-based tip confirmation technology, aimed at enhancing precision and patient safety during catheter placements.

Future Market Scenario (2025-2032F)

The United States vascular access devices market is expected to witness robust growth due to rising hospital admissions, the increasing burden of chronic diseases, and technological innovations in catheter materials and placement systems. Growing demand for minimally invasive procedures and enhanced infection prevention measures will also support market expansion. Additionally, supportive reimbursement frameworks and ongoing clinical innovations are likely to create new opportunities across hospitals and ambulatory surgical centers. BD (Becton, Dickinson and Company) introduced the PIVO Pro, a ground-breaking needleless blood collection tool, in November 2023. Upon FDA approval, the device became the first to function smoothly with both integrated and long-term peripheral IV catheters, including the Nexiva system, which now features NearPort IV Access.

Key Players Landscape and Outlook

The key players in the market are significantly investing in the development of vascular access devices and are utilizing strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing large-cap industry players to increase their presence and, therefore, find new opportunities in this market.

Mozarc Medical, a joint venture between Medtronic (India Medtronic Private Limited) and DaVita Inc., aimed at promoting advancements in kidney treatment, was established in April 2023. Mozarc wants to improve accessibility and flexibility for people with chronic renal disease by creating home-based and portable dialysis systems. The program demonstrates both businesses' dedication to using technology and patient-centered care to revolutionize kidney health management.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. United States Vascular Access Devices Market Outlook, 2018-2032F

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
  • 5.1.2. By Volume
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Product Type
    • 5.2.1.1. Central Vascular Access Device
    • 5.2.1.2. Peripheral Vascular Access Device
    • 5.2.1.3. Accessories
  • 5.2.2. By Application
    • 5.2.2.1. Drug Administration
    • 5.2.2.2. Fluid and Nutrition Administration
    • 5.2.2.3. Blood Transfusion
    • 5.2.2.4. Diagnostics
  • 5.2.3. By End-user
    • 5.2.3.1. Hospitals
    • 5.2.3.2. Clinics
    • 5.2.3.3. Ambulatory Surgical Centers
    • 5.2.3.4. Others
  • 5.2.4. By Region
    • 5.2.4.1. Northeast
    • 5.2.4.2. Midwest
    • 5.2.4.3. West
    • 5.2.4.4. South
  • 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 5.3. Market Map Analysis, 2024
  • 5.3.1. By Product Type
  • 5.3.2. By Application
  • 5.3.3. By End-user
  • 5.3.4. By Region

6. Value Chain Analysis

7. Demand Supply Analysis

8. Import and Export Analysis

9. Porter's Five Forces Analysis

10. PESTLE Analysis

11. Pricing Analysis

12. Market Dynamics

• 12.1. Market Drivers
• 12.2. Market Challenges

13. Market Trends and Developments

14. Regulatory Framework and Innovation

15. Competitive Landscape

• 15.1. Competition Matrix of Top 5 Market Leaders
• 15.2. SWOT Analysis for Top 5 Players
• 15.3. Key Players Landscape for Top 10 Market Players
  • 15.3.1. Becton, Dickinson and Company
    • 15.3.1.1. Company Details
    • 15.3.1.2. Key Management Personnel
    • 15.3.1.3. Products and Services
    • 15.3.1.4. Financials (As Reported)
    • 15.3.1.5. Key Market Focus and Geographical Presence
    • 15.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 15.3.2. Teleflex Incorporated
  • 15.3.3. Nipro Medical Corporation
  • 15.3.4. ICU Medical, Inc.
  • 15.3.5. AngioDynamics, Inc.
  • 15.3.6. Medtronic plc
  • 15.3.7. Braun Holding GMBH & Co. KG
  • 15.3.8. Terumo Corporation
  • 15.3.9. Cook Medical Inc.
  • 15.3.10. Access Vascular Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

16. Strategic Recommendations

17. About Us and Disclaimer

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. United States Vascular Access Devices Market, By Value, In USD Million, 2018-2032F
• Figure 2. United States Vascular Access Devices Market, By Volume, In Units, 2018-2032F
• Figure 3. United States Vascular Access Devices Market Share (%), By Product Type, 2018-2032F
• Figure 4. United States Vascular Access Devices Market Share (%), By Application, 2018-2032F
• Figure 5. United States Vascular Access Devices Market Share (%), By End-user, 2018-2032F
• Figure 6. United States Vascular Access Devices Market Share (%), By Region, 2018-2032F
• Figure 7. By Product Type Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 8. By Application Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 9. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 10. By Region Map-Market Size (USD Million) & Growth Rate (%), 2024